To improve the world's food supply through the scientific research, development, and application of natural PPFM bacteria to plants and agricultural crops.
NewLeaf Symbiotics was formed in 2012 to develop and commercialize one of the most prevalent, beneficial bacteria found in nature: PPFMs (Pink Pigmented Facultative Methylotrophs). NewLeaf Symbiotics is the exclusive licensee of a number of patents on the use of this family of bacteria. NewLeaf Symbiotics has also filed its own related patents, and is actively developing new technologies related to PPFMs. The Company is engaged in laboratory, greenhouse, and field product trials and expects to commercialize and license products beginning in 2014.
Bernard is the former COO of Monsanto Agriculture and former President and Chairman of the Board of Monsanto Europe. He originally trained as an agricultural engineer and lectures throughout the world on the future of agriculture. Bernard is currently Managing Director, Europe for the Executive Search group Kincannon & Reed, and a Partner at Alber & Geiger, the Brussels-based EU lobbying firm.
Dr. Holland earned his PhD in Horticulture at Rutgers University. He is a Professor of Biology at Salisbury University (University of Maryland system) and past president of the Washington Academy of Science. He made the original discoveries that led to the development of NewLeaf Symbiotics' PPFM technology.
Dr. Shah holds a PhD in Genetics and is a Principal Investigator at the Donald Danforth Plant Sciences Center, where he focuses on plant/microbial interactions. He is a co-inventor on 13 patents that are considered transformational in world agriculture, including the invention of technologies that led to the creation of glyphosate-resistant crops.